There was no difference, neither in age (56.1 ± 8.5 versus 55.9 ± 10.1 years, p = 0.771), duration of infection (14.5 ± 8.0 versus 16.8 ± 7.7 years, p = 0.168) nor aviremia (7.0 ± 3.5 versus 8.3 ± 4.2 years, p = 0.155), nor in pretherapeutic CD4 count (164 ± 110 versus 159 ± 103 cells/mL, p = 0.980) nor pretherapeutic viremia (4,782,630 ± 20,381,332 versus 530,006 ± 1,733,809 copies/mL, p = 0.831) between patients with detectable and undetectable viremia, respectively. Here, CD4 is linked to infection.